Global Companion Diagnostics Market Size, Status and Forecast 2022 : Roche Diagnostics, Abbott Laboratories, Agilent Technologies
Qyresearchreports include new market research report
“Global Companion Diagnostics Market Size, Status and Forecast 2022" to
its huge collection of research reports.
The global Companion Diagnostics market is forever evolving, and hence several factors will define the future prospects. This report has been created to serve as a dependable business document for the stakeholders attached to the value chain of the global Companion Diagnostics market, analyzing all the important factors, catching the latest trends, and estimating the future scenario. The report has been prepared using conventional research methodologies such as SWOT Analysis and Porter’s Five Forces.
To Get Sample Copy of Report visit @ http://www.qyresearchreports.com/sample/sample.php?rep_id=1034303&type=E
In order to gauge the potential of various segments of product, application, and end-use, the report takes each one at a time and provides future prospects. This report on the global Companion Diagnostics market also takes stocks of various regions, identifies the most lucrative country-wide markets, and takes notes of the level of competition coming from regional players. To evaluate market size, the report has considered several data points such as market split and regional split on the basis of source, product and qualitative inputs from primary responses have been taken into account to deduce suitable market estimates. The forecasts presented in this report calculates the total revenue that is anticipated to be generated across the Companion Diagnostics market over forecast period 2017-2022.
In order to form a picture of the competitive landscape, the report has profiled a number of leading players in the global Companion Diagnostics market. For each player, the report overviews their geographical reach, estimates share of the pie, and analyzes the recent strategic developments such as acquisitions and agreements, marketing strategies, and customer relationship.
Table of Contents
Global Companion Diagnostics Market Size, Status and Forecast 2022
1 Industry Overview of Companion Diagnostics
1.1 Companion Diagnostics Market Overview
1.1.1 Companion Diagnostics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Companion Diagnostics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Companion Diagnostics Market by Type
1.3.1 Polymerase Chain Reaction Test (PCR)
1.3.2 Immunohistochemistry Test (IHC)
1.3.3 In Situ Hybridization Test (ISH)
1.3.4 Others
1.4 Companion Diagnostics Market by End Users/Application
1.4.1 Breast Cancer
1.4.2 Non-Small Cell Lung Cancer (NSCLC)
1.4.3 Colorectal Cancer (CRC)
1.4.4 Melanoma Cancer
1.4.5 Gastric Cancer
1.4.6 Others
2 Global Companion Diagnostics Competition Analysis by Players
2.1 Companion Diagnostics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
Browse Complete Report with TOC @ http://www.qyresearchreports.com/report/global-companion-diagnostics-market-size-status-and-forecast-2022.html
3 Company (Top Players) Profiles
3.1 Roche Diagnostics
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Abbott Laboratories
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Agilent Technologies
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 QIAGEN NV
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Thermo Fisher Scientific
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Myriad Genetics
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Abbott Laboratories
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Advanced Cell Diagnostics
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Agilent Technologies
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 BiomRieux
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Biogenex Laboratories
3.12 Danaher Corporation
3.13 GE Healthcare
3.14 Myriad Genetics
3.15 Qiagen N.V
3.16 Roche Diagnostics
3.17 Thermo Fisher Scientific
3.18 R-Biopharm
3.19 Cypher Genomics
3.20 Flagship Biosciences
3.21 Applied Proteomics
3.22 Ignyta
3.23 Madison Vaccines
3.24 Ventana Medical Systems
4 Global Companion Diagnostics Market Size by Type and Application (2012-2017)
4.1 Global Companion Diagnostics Market Size by Type (2012-2017)
4.2 Global Companion Diagnostics Market Size by Application (2012-2017)
4.3 Potential Application of Companion Diagnostics in Future
4.4 Top Consumer/End Users of Companion Diagnostics
About Us
QYReseachReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYReseachReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.
Contact Us
1820 Avenue
M Suite #1047
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-621-2074
Web: http://www.qyresearchreports.com
Email: sales@qyresearchreports.com
The global Companion Diagnostics market is forever evolving, and hence several factors will define the future prospects. This report has been created to serve as a dependable business document for the stakeholders attached to the value chain of the global Companion Diagnostics market, analyzing all the important factors, catching the latest trends, and estimating the future scenario. The report has been prepared using conventional research methodologies such as SWOT Analysis and Porter’s Five Forces.
To Get Sample Copy of Report visit @ http://www.qyresearchreports.com/sample/sample.php?rep_id=1034303&type=E
In order to gauge the potential of various segments of product, application, and end-use, the report takes each one at a time and provides future prospects. This report on the global Companion Diagnostics market also takes stocks of various regions, identifies the most lucrative country-wide markets, and takes notes of the level of competition coming from regional players. To evaluate market size, the report has considered several data points such as market split and regional split on the basis of source, product and qualitative inputs from primary responses have been taken into account to deduce suitable market estimates. The forecasts presented in this report calculates the total revenue that is anticipated to be generated across the Companion Diagnostics market over forecast period 2017-2022.
In order to form a picture of the competitive landscape, the report has profiled a number of leading players in the global Companion Diagnostics market. For each player, the report overviews their geographical reach, estimates share of the pie, and analyzes the recent strategic developments such as acquisitions and agreements, marketing strategies, and customer relationship.
Table of Contents
Global Companion Diagnostics Market Size, Status and Forecast 2022
1 Industry Overview of Companion Diagnostics
1.1 Companion Diagnostics Market Overview
1.1.1 Companion Diagnostics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Companion Diagnostics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Companion Diagnostics Market by Type
1.3.1 Polymerase Chain Reaction Test (PCR)
1.3.2 Immunohistochemistry Test (IHC)
1.3.3 In Situ Hybridization Test (ISH)
1.3.4 Others
1.4 Companion Diagnostics Market by End Users/Application
1.4.1 Breast Cancer
1.4.2 Non-Small Cell Lung Cancer (NSCLC)
1.4.3 Colorectal Cancer (CRC)
1.4.4 Melanoma Cancer
1.4.5 Gastric Cancer
1.4.6 Others
2 Global Companion Diagnostics Competition Analysis by Players
2.1 Companion Diagnostics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
Browse Complete Report with TOC @ http://www.qyresearchreports.com/report/global-companion-diagnostics-market-size-status-and-forecast-2022.html
3 Company (Top Players) Profiles
3.1 Roche Diagnostics
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Abbott Laboratories
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Agilent Technologies
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 QIAGEN NV
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Thermo Fisher Scientific
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Myriad Genetics
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Abbott Laboratories
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Advanced Cell Diagnostics
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Agilent Technologies
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 BiomRieux
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Companion Diagnostics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Biogenex Laboratories
3.12 Danaher Corporation
3.13 GE Healthcare
3.14 Myriad Genetics
3.15 Qiagen N.V
3.16 Roche Diagnostics
3.17 Thermo Fisher Scientific
3.18 R-Biopharm
3.19 Cypher Genomics
3.20 Flagship Biosciences
3.21 Applied Proteomics
3.22 Ignyta
3.23 Madison Vaccines
3.24 Ventana Medical Systems
4 Global Companion Diagnostics Market Size by Type and Application (2012-2017)
4.1 Global Companion Diagnostics Market Size by Type (2012-2017)
4.2 Global Companion Diagnostics Market Size by Application (2012-2017)
4.3 Potential Application of Companion Diagnostics in Future
4.4 Top Consumer/End Users of Companion Diagnostics
About Us
QYReseachReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYReseachReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.
Contact Us
1820 Avenue
M Suite #1047
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-621-2074
Web: http://www.qyresearchreports.com
Email: sales@qyresearchreports.com
Comments
Post a Comment